Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Mol Cell Biol. 1995 Jul; 15(7): 3870–3881.
doi: 10.1128/mcb.15.7.3870
PMCID: PMC230627
PMID: 7791794

Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line.

B M Evers, X Wang, Z Zhou, C M Townsend, Jr, G P McNeil, and P R Dobner
Author information Copyright and License information Disclaimer

Abstract

Expression of the gene encoding neurotensin/neuromedin N (NT/N) is mostly limited to the brain and specialized enteroendocrine cells (N cells) of the distal small intestine. We have analyzed the NT/N DNA sequences upstream of the RNA start site that direct cell-specific expression using a novel human endocrine cell line, BON, that resembles intestinal N cells in several important aspects, including NT/N precursor protein processing, ratios of different NT/N mRNA forms, and high levels of constitutive expression of the NT/N gene. Transient transfection assays with plasmids with progressive 5' deletions of the rat NT/N promoter identified the proximal 216 bp of 5' flanking sequences as essential for high-level constitutive NT/N expression in BON cells. In addition, a detailed mutational analysis defined multiple regions within the proximal 216 bp that contribute to cell-specific NT/N expression. These elements include a proximal cyclic AMP response element (CRE)/AP-1-like motif (TGACATCA) that binds c-Jun, JunD, CRE-binding (CREB), and ATF proteins, a near-consensus glucocorticoid response element, and a distal consensus AP-1 site that binds c-Fos, Fra-1, and JunD. In addition, elements contained within two 21-bp imperfect direct repeats play an important role in NT/N expression in BON cells and may bind novel factors that act as positive regulators of NT/N expression. DNase I footprinting and gel shift analyses demonstrate that the sites identified by mutational analysis, and at least one additional site, specifically bind BON cell nuclear proteins in vitro. We speculate that a complex pattern of regulation requiring interaction between a proximal CRE/AP-1-like motif and other upstream control elements play an important role in the high-level constitutive expression of NT/N in the human endocrine cell line BON. In addition, the BON cell line provides a unique model to further characterize the factors regulating cell-specific NT/N expression and to better understand the mechanisms responsible for the terminal differentiation of the N-cell lineage in the gut.

Full Text

The Full Text of this article is available as a PDF (621K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Agre P, Johnson PF, McKnight SL. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science. 1989 Nov 17;246(4932):922–926. [PubMed] [Google Scholar]
  • Andersson S, Rosell S, Hjelmquist U, Chang D, Folkers K. Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand. 1977 Jun;100(2):231–235. [PubMed] [Google Scholar]
  • Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 1988 Dec 2;55(5):875–885. [PubMed] [Google Scholar]
  • Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. [PubMed] [Google Scholar]
  • Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol. 1993 Apr;13(4):2235–2246. [PMC free article] [PubMed] [Google Scholar]
  • Armstrong MJ, Parker MC, Ferris CF, Leeman SE. Neurotensin stimulates [3H]oleic acid translocation across rat small intestine. Am J Physiol. 1986 Dec;251(6 Pt 1):G823–G829. [PubMed] [Google Scholar]
  • Atchison ML. Enhancers: mechanisms of action and cell specificity. Annu Rev Cell Biol. 1988;4:127–153. [PubMed] [Google Scholar]
  • Baca I, Feurle GE, Schwab A, Mittmann U, Knauf W, Lehnert T. Effect of neurotensin on exocrine pancreatic secretion in dogs. Digestion. 1982;23(3):174–183. [PubMed] [Google Scholar]
  • Barber DL, Buchan AM, Walsh JH, Soll AH. Isolated canine ileal mucosal cells in short-term culture: a model for study of neurotensin release. Am J Physiol. 1986 Mar;250(3 Pt 1):G374–G384. [PubMed] [Google Scholar]
  • Bean AJ, Dagerlind A, Hökfelt T, Dobner PR. Cloning of human neurotensin/neuromedin N genomic sequences and expression in the ventral mesencephalon of schizophrenics and age/sex matched controls. Neuroscience. 1992 Sep;50(2):259–268. [PubMed] [Google Scholar]
  • Bebenek K, Kunkel TA. The use of native T7 DNA polymerase for site-directed mutagenesis. Nucleic Acids Res. 1989 Jul 11;17(13):5408–5408. [PMC free article] [PubMed] [Google Scholar]
  • Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 1989 Aug;3(8):1146–1156. [PubMed] [Google Scholar]
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. [PubMed] [Google Scholar]
  • Brand SJ, Fuller PJ. Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem. 1988 Apr 15;263(11):5341–5347. [PubMed] [Google Scholar]
  • Busch SJ, Sassone-Corsi P. Dimers, leucine zippers and DNA-binding domains. Trends Genet. 1990 Feb;6(2):36–40. [PubMed] [Google Scholar]
  • Carey M. Mechanistic advances in eukaryotic gene activation. Curr Opin Cell Biol. 1991 Jun;3(3):452–460. [PubMed] [Google Scholar]
  • Carraway RE, Mitra SP, Evers BM, Townsend CM., Jr BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing. Regul Pept. 1994 Aug 31;53(1):17–29. [PubMed] [Google Scholar]
  • Carraway RE, Mitra SP, Feurle GE, Hacki WH. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor. J Clin Endocrinol Metab. 1988 Jun;66(6):1323–1328. [PubMed] [Google Scholar]
  • Chodosh LA, Baldwin AS, Carthew RW, Sharp PA. Human CCAAT-binding proteins have heterologous subunits. Cell. 1988 Apr 8;53(1):11–24. [PubMed] [Google Scholar]
  • Chung DH, Evers BM, Shimoda I, Townsend CM, Jr, Rajaraman S, Thompson JC. Effect of neurotensin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas. Gastroenterology. 1992 Oct;103(4):1254–1259. [PubMed] [Google Scholar]
  • Curran T, Franza BR., Jr Fos and Jun: the AP-1 connection. Cell. 1988 Nov 4;55(3):395–397. [PubMed] [Google Scholar]
  • de Nadai F, Rovere C, Bidard JN, Laur J, Martinez J, Cuber JC, Kitabgi P. Biosynthesis and posttranslational processing of the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line. Effect of dexamethasone. Endocrinology. 1993 Apr;132(4):1614–1620. [PubMed] [Google Scholar]
  • Dobner PR, Tischler AS, Lee YC, Bloom SR, Donahue SR. Lithium dramatically potentiates neurotensin/neuromedin N gene expression. J Biol Chem. 1988 Oct 5;263(28):13983–13986. [PubMed] [Google Scholar]
  • Du W, Maniatis T. An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected]. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2150–2154. [PMC free article] [PubMed] [Google Scholar]
  • Dynan WS. Modularity in promoters and enhancers. Cell. 1989 Jul 14;58(1):1–4. [PubMed] [Google Scholar]
  • Evers BM, Townsend CM, Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, Rajaraman S, Singh P, Reubi JC, Thompson JC. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology. 1991 Aug;101(2):303–311. [PubMed] [Google Scholar]
  • Evers BM, Ehrenfried JA, Wang X, Townsend CM, Jr, Thompson JC. Temporal-specific and spatial-specific patterns of neurotensin gene expression in the small bowel. Am J Physiol. 1994 Nov;267(5 Pt 1):G875–G882. [PubMed] [Google Scholar]
  • Evers BM, Ishizuka J, Townsend CM, Jr, Rajaraman S, Thompson JC. Expression of neurotensin messenger RNA in a human carcinoid tumor. Ann Surg. 1991 Oct;214(4):448–455. [PMC free article] [PubMed] [Google Scholar]
  • Evers BM, Izukura M, Chung DH, Parekh D, Yoshinaga K, Greeley GH, Jr, Uchida T, Townsend CM, Jr, Thompson JC. Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology. 1992 Jul;103(1):86–91. [PubMed] [Google Scholar]
  • Evers BM, Izukura M, Rajaraman S, Parekh D, Thakore K, Yoshinaga K, Uchida T, Townsend CM, Jr, Thompson JC. Effect of aging on neurotensin-stimulated growth of rat small intestine. Am J Physiol. 1994 Aug;267(2 Pt 1):G180–G186. [PubMed] [Google Scholar]
  • Evers BM, Izukura M, Townsend CM, Jr, Uchida T, Thompson JC. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci. 1992 Mar;37(3):426–431. [PubMed] [Google Scholar]
  • Evers BM, Rajaraman S, Chung DH, Townsend CM, Jr, Wang X, Graves K, Thompson JC. Differential expression of the neurotensin gene in the developing rat and human gastrointestinal tract. Am J Physiol. 1993 Sep;265(3 Pt 1):G482–G490. [PubMed] [Google Scholar]
  • Ferris CF, Carraway RE, Hammer RA, Leeman SE. Release and degradation of neurotensin during perfusion of rat small intestine with lipid. Regul Pept. 1985 Oct;12(2):101–111. [PubMed] [Google Scholar]
  • Feurle GE, Müller B, Rix E. Neurotensin induces hyperplasia of the pancreas and growth of the gastric antrum in rats. Gut. 1987;28 (Suppl):19–23. [PMC free article] [PubMed] [Google Scholar]
  • Friedman AD, Landschulz WH, McKnight SL. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev. 1989 Sep;3(9):1314–1322. [PubMed] [Google Scholar]
  • Georgopoulos K, Galson D, Terhorst C. Tissue-specific nuclear factors mediate expression of the CD3 delta gene during T cell development. EMBO J. 1990 Jan;9(1):109–115. [PMC free article] [PubMed] [Google Scholar]
  • Georgopoulos K, Morgan BA, Moore DD. Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol Cell Biol. 1992 Feb;12(2):747–757. [PMC free article] [PubMed] [Google Scholar]
  • Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. [PMC free article] [PubMed] [Google Scholar]
  • Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. [PubMed] [Google Scholar]
  • Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424–2428. [PMC free article] [PubMed] [Google Scholar]
  • Habener JF. Cyclic AMP response element binding proteins: a cornucopia of transcription factors. Mol Endocrinol. 1990 Aug;4(8):1087–1094. [PubMed] [Google Scholar]
  • Hall CV, Jacob PE, Ringold GM, Lee F. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J Mol Appl Genet. 1983;2(1):101–109. [PubMed] [Google Scholar]
  • Izukura M, Evers BM, Parekh D, Yoshinaga K, Uchida T, Townsend CM, Jr, Thompson JC. Neurotensin augments intestinal regeneration after small bowel resection in rats. Ann Surg. 1992 May;215(5):520–527. [PMC free article] [PubMed] [Google Scholar]
  • Jantzen HM, Strähle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R, Schütz G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell. 1987 Apr 10;49(1):29–38. [PubMed] [Google Scholar]
  • Karlsson O, Edlund T, Moss JB, Rutter WJ, Walker MD. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8819–8823. [PMC free article] [PubMed] [Google Scholar]
  • Kaszubska W, Hooft van Huijsduijnen R, Ghersa P, DeRaemy-Schenk AM, Chen BP, Hai T, DeLamarter JF, Whelan J. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol. 1993 Nov;13(11):7180–7190. [PMC free article] [PubMed] [Google Scholar]
  • Kennedy GC, Rutter WJ. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11498–11502. [PMC free article] [PubMed] [Google Scholar]
  • Kislauskis E, Bullock B, McNeil S, Dobner PR. The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences. J Biol Chem. 1988 Apr 5;263(10):4963–4968. [PubMed] [Google Scholar]
  • Kislauskis E, Dobner PR. Mutually dependent response elements in the cis-regulatory region of the neurotensin/neuromedin N gene integrate environmental stimuli in PC12 cells. Neuron. 1990 May;4(5):783–795. [PubMed] [Google Scholar]
  • Krasinski SD, Wheeler MB, Leiter AB. Isolation, characterization, and developmental expression of the rat peptide-YY gene. Mol Endocrinol. 1991 Mar;5(3):433–440. [PubMed] [Google Scholar]
  • Lamph WW, Dwarki VJ, Ofir R, Montminy M, Verma IM. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4320–4324. [PMC free article] [PubMed] [Google Scholar]
  • Le Douarin NM. On the origin of pancreatic endocrine cells. Cell. 1988 Apr 22;53(2):169–171. [PubMed] [Google Scholar]
  • Lee KA. Dimeric transcription factor families: it takes two to tango but who decides on partners and the venue? J Cell Sci. 1992 Sep;103(Pt 1):9–14. [PubMed] [Google Scholar]
  • Lum LS, Sultzman LA, Kaufman RJ, Linzer DI, Wu BJ. A cloned human CCAAT-box-binding factor stimulates transcription from the human hsp70 promoter. Mol Cell Biol. 1990 Dec;10(12):6709–6717. [PMC free article] [PubMed] [Google Scholar]
  • Masquilier D, Sassone-Corsi P. Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem. 1992 Nov 5;267(31):22460–22466. [PubMed] [Google Scholar]
  • Maxam AM, Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499–560. [PubMed] [Google Scholar]
  • Merchant KM. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum. Mol Cell Neurosci. 1994 Aug;5(4):336–344. [PubMed] [Google Scholar]
  • Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989 Jul 28;245(4916):371–378. [PubMed] [Google Scholar]
  • Montminy MR, Sevarino KA, Wagner JA, Mandel G, Goodman RH. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6682–6686. [PMC free article] [PubMed] [Google Scholar]
  • Moses HL, Proper JA, Volkenant ME, Wells DJ, Getz MJ. Mechanism of growth arrest of chemically transformed cells in culture. Cancer Res. 1978 Sep;38(9):2807–2812. [PubMed] [Google Scholar]
  • Muraki K, Mitra SP, Dobner PR, Carraway RE. Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats. Peptides. 1993 Nov-Dec;14(6):1095–1102. [PubMed] [Google Scholar]
  • Nordeen SK. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988 May;6(5):454–458. [PubMed] [Google Scholar]
  • Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood. 1992 Aug 1;80(3):575–581. [PubMed] [Google Scholar]
  • Parekh D, Ishizuka J, Townsend CM, Jr, Haber B, Beauchamp RD, Karp G, Kim SW, Rajaraman S, Greeley G, Jr, Thompson JC. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas. 1994 Jan;9(1):83–90. [PubMed] [Google Scholar]
  • Pescini R, Kaszubska W, Whelan J, DeLamarter JF, Hooft van Huijsduijnen R. ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. J Biol Chem. 1994 Jan 14;269(2):1159–1165. [PubMed] [Google Scholar]
  • Ptashne M. How eukaryotic transcriptional activators work. Nature. 1988 Oct 20;335(6192):683–689. [PubMed] [Google Scholar]
  • Reinecke M. Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog Histochem Cytochem. 1985;16(1):1–172. [PubMed] [Google Scholar]
  • Ryden TA, Beemon K. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein. Mol Cell Biol. 1989 Mar;9(3):1155–1164. [PMC free article] [PubMed] [Google Scholar]
  • Shapiro DJ, Sharp PA, Wahli WW, Keller MJ. A high-efficiency HeLa cell nuclear transcription extract. DNA. 1988 Jan-Feb;7(1):47–55. [PubMed] [Google Scholar]
  • Sirinathsinghji DJ, Schuligoi R, Heavens RP, Dixon A, Iversen SD, Hill RG. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist. Neuroscience. 1994 Sep;62(2):407–423. [PubMed] [Google Scholar]
  • Soll AH. Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol. 1980 Apr;238(4):G366–G375. [PubMed] [Google Scholar]
  • Theodorsson-Norheim E, Oberg K, Rosell S, Boström H. Neurotensinlike immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut. Gastroenterology. 1983 Oct;85(4):881–889. [PubMed] [Google Scholar]
  • Thor K, Rosell S. Neurotensin increases colonic motility. Gastroenterology. 1986 Jan;90(1):27–31. [PubMed] [Google Scholar]
  • Tischler AS, Lee YC, Costopoulos D, Slayton VW, Jason WJ, Bloom SR. Cooperative regulation of neurotensin content in PC12 pheochromocytoma cell cultures: effects of nerve growth factor, dexamethasone, and activators of adenylate cyclase. J Neurosci. 1986 Jun;6(6):1719–1725. [PMC free article] [PubMed] [Google Scholar]
  • Wang TC, Brand SJ. Islet cell-specific regulatory domain in the gastrin promoter contains adjacent positive and negative DNA elements. J Biol Chem. 1990 May 25;265(15):8908–8914. [PubMed] [Google Scholar]
  • Wheeler MB, Nishitani J, Buchan AM, Kopin AS, Chey WY, Chang TM, Leiter AB. Identification of a transcriptional enhancer important for enteroendocrine and pancreatic islet cell-specific expression of the secretin gene. Mol Cell Biol. 1992 Aug;12(8):3531–3539. [PMC free article] [PubMed] [Google Scholar]
  • Wood JG, Hoang HD, Bussjaeger LJ, Solomon TE. Neurotensin stimulates growth of small intestine in rats. Am J Physiol. 1988 Dec;255(6 Pt 1):G813–G817. [PubMed] [Google Scholar]
  • Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer. 1977 Jan;19(1):128–135. [PubMed] [Google Scholar]
  • Zeytinoğlu FN, Brazeau P, Mougin C. Regulation of neurotensin secretion in a mammalian C cell line: effect of dexamethasone. Regul Pept. 1983 May;6(2):147–154. [PubMed] [Google Scholar]
Articles from Molecular and Cellular Biology are provided here courtesy of American Society for Microbiology (ASM)